Page 188 - Read Online

Sobenin et al. Is insulin atherogenic?

40. Capron L, Jarnet J. Effects of injury and insulin on lipid synthesis from 50. Polak JF, Backlund JY, Cleary PA, Harrington AP, O’Leary DH,
glucose by the rat thoracic aorta. Arterioscler Thromb 1991;11:91-6. Lachin JM, Nathan DM; DCCT/EDIC Research Group. Progression
41. Pfeifle B, Ditschuneit HH, Ditschuneit H. Insulin as a cellular growth of carotid artery intima-media thickness during 12 years in the diabetes
regulator of rat arterial smooth muscle cells in vitro. Horm Metab Res control and complications trial/epidemiology of diabetes interventions
1980;12:381-5. and complications (DCCT/EDIC) study. Diabetes 2011;60:607-13.
42. King GL, Buzney SM, Kahn CR, Hetu N, Buchwald S, Macdonald 51. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-
SG, Rand LI. Differential responsiveness to insulin of endothelial glucose control with sulphonylureas or insulin compared with
and support cells from micro- and macrovessels. J Clin Invest conventional treatment and risk of complications in patients with type
1983;71:974-9. 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
43. Ledet T. Growth hormone stimulating the growth of arterial medial 52. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year
cells in vitro. Absence of effect of insulin. Diabetes 1976;25:1011-7. follow-up of intensive glucose control in type 2 diabetes. N Engl J
44. Baandrup U, Ledet T, Rasch R. Experimental diabetic cardiopathy Med 2008;359:1577-89.
preventable by insulin treatment. Lab Invest 1981;45:169-73. 53. Action to Control Cardiovascular Risk in Diabetes Study Group;
45. Ridray S, Ktorza A, Picon L, Capron L. In vivo effect of insulin on Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse
the acute proliferative response of the rat aorta to injury. Arterioscler JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield
Thromb 1992;12:633-8. JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose
46. Joseph JJ, Donner TW. Long-term insulin glargine therapy in type 2 lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59.
diabetes mellitus: a focus on cardiovascular outcomes. Vasc Health 54. Advance Collaborative Group; Patel A, MacMahon S, Chalmers J,
Risk Manag 2015;11:107-16. Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P,
47. Diabetes Control and Complications Trial Research Group; Nathan Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen
DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de
L, Siebert C. The effect of intensive treatment of diabetes on the Galan BE, Joshi R, Travert F. Intensive blood glucose control and
development and progression of long-term complications in insulin- vascular outcomes in patients with type 2 diabetes. N Engl J Med
dependent diabetes mellitus. N Engl J Med 1993;329:977-86. 2008;358:2560-72.
48. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, 55. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven
Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman
Trial/Epidemiology of Diabetes Interventions and Complications S, McCarren M, Vitek ME, Henderson WG, Huang GD; VADT
(DCCT/EDIC) Study Research Group. Intensive diabetes treatment Investigators. Glucose control and vascular complications in veterans
and cardiovascular disease in patients with type 1 diabetes. N Engl J with type 2 diabetes. N Engl J Med 2009;360:129-39.
Med 2005;353:2643-53. 56. Riddle MC. Effects of intensive glucose lowering in the management
49. Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund of patients with type 2 diabetes mellitus in the action to control
JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM; DCCT/ cardiovascular risk in diabetes (ACCORD) trial. Circulation
EDIC Research Group. The effect of intensive glycemic treatment 2010;122:844-6.
on coronary artery calcification in type 1 diabetic participants of the 57. Fang HJ, Zhou YH, Tian YJ, Du HY, Sun YX, Zhong LY. Effects of
diabetes control and complications trial/epidemiology of diabetes intensive glucose lowering in treatment of type 2 diabetes mellitus on
interventions and complications (DCCT/EDIC) study. Diabetes cardiovascular outcomes: a meta-analysis of data from 58,160 patients
2006;55:3556-65. in 13 randomized controlled trials. Int J Cardiol 2016;218:50-8.

Vessel Plus ¦ Volume 1 ¦ December 28, 2017 181